Human beta-defensin 1: From defence to offence

Zeitschrift fur Gastroenterologie

Volumn 50, Issue 11, 2012, Pages 1171-1175

  Schroeder, B O ^a   Stange, E F ^b   Wehkamp, J ^a,b  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^b ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

chronic inflammatory bowel disease; commensal bacteria; defensin; hBD 1

Indexed keywords

BETA DEFENSIN 1; BETA DEFENSIN; DEFB1 PROTEIN, HUMAN;

ARTICLE; BACTERIAL COLONIZATION; COMMENSALISM; ENTERITIS; GENE ACTIVATION; GENETIC POLYMORPHISM; HUMAN; IMMUNOCOMPETENT CELL; INTESTINE EPITHELIUM; INTESTINE FLORA; NONHUMAN; PROTEIN FUNCTION; REDUCTION; BACTERIAL TRANSLOCATION; BACTERIUM; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; INTESTINE MUCOSA; MICROBIOLOGY; MUCOSAL IMMUNITY; OXIDATION REDUCTION REACTION; PATHOGENICITY; REVIEW; VIRULENCE;

BACTERIA; BACTERIAL TRANSLOCATION; BETA-DEFENSINS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; OXIDATION-REDUCTION; POLYMORPHISM, GENETIC; VIRULENCE;

EID: 84868669984     PISSN: 00442771     EISSN: 14397803     Source Type: Journal    
DOI: 10.1055/s-0032-1312865     Document Type: Article

References (55)

1. Savage D. C. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol: 1977; 31 107 133
2. Eckburg P. B., Bik E. M., Bernstein C. N. et al. Diversity of the human intestinal microbial flora. Science: 2005; 308 1635 1638 (Pubitemid 40807514)
3. Turnbaugh P. J., Hamady M., Yatsunenko T. et al. A core gut microbiome in obese and lean twins. Nature: 2009; 457 480 484
4. Qin J., Li R., Raes J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature: 2010; 464 59 124
5. Arumugam M., Raes J., Pelletier E. et al. Enterotypes of the human gut microbiome. Nature: 2011; 473 174 254
6. Spor A., Koren O., Ley R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol: 2011; 9 279 290
7. Ley R. E., Turnbaugh P. J., Klein S. et al. Microbial ecology: human gut microbes associated with obesity. Nature: 2006; 444 1022 1023 (Pubitemid 46018512)
8. Larsen N., Vogensen F. K., van den Berg F. WJ et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE: 2010; 5 e9085
9. Frank D. N., St Amand A. L., Feldman R. A. et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci. USA: 2007; 104 13780 13785 (Pubitemid 350003397)
10. Sartor R. B. Microbial influences in inflammatory bowel diseases. Gastroenterology: 2008; 134 577 594 (Pubitemid 351173057)
11. Fraune S., Bosch T. CG. Long-term maintenance of species-specific bacterial microbiota in the basal metazoan Hydra. Proc Natl Acad Sci USA: 2007; 104 13146 13151 (Pubitemid 351737607)
12. Louis P., Scott K. P., Duncan S. H. et al. Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol: 2007; 102 1197 1208 (Pubitemid 46633434)
13. Vaishnava S., Behrendt C. L., Ismail A. S. et al. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci USA: 2008; 105 20858 20863
14. Salzman N. H., Hung K., Haribhai D. et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol: 2010; 11 76 83
15. Zasloff M. Antibiotic peptides as mediators of innate immunity. Curr Opin Immunol: 1992; 4 3 7
16. Lehrer R. I., Ganz T. Antimicrobial peptides in mammalian and insect host defence. Curr Opin Immunol: 1999; 11 23 27 (Pubitemid 29082332)
17. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol: 2003; 3 710 720 (Pubitemid 41070812)
18. Harder J., Gläser R., Schröder J. M. Human antimicrobial proteins effectors of innate immunity. J Endotoxin Res: 2007; 13 317 338
19. Lehrer R. I., Ganz T., Selsted M. E. Defensins: endogenous antibiotic peptides of animal cells. Cell: 1991; 64 229 230 (Pubitemid 121001251)
20. Martin E., Ganz T., Lehrer R. I. Defensins and other endogenous peptide antibiotics of vertebrates. J Leukoc Biol: 1995; 58 128 136
21. Ericksen B., Wu Z., Lu W. et al. Antibacterial activity and specificity of the six human {alpha}-defensins. Antimicrob Agents Chemother: 2005; 49 269 275 (Pubitemid 40065802)
22. Porter E. M., Liu L., Oren A. et al. Localization of human intestinal defensin 5 in Paneth cell granules. Infect Immun: 1997; 65 2389 2395 (Pubitemid 27237325)
23. Wehkamp J., Chu H., Shen B. et al. Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues. FEBS Lett: 2006; 580 5344 5350 (Pubitemid 44419568)
24. Bensch K. W., Raida M., Mägert H. J. et al. hBD-1: a novel beta-defensin from human plasma. FEBS Lett: 1995; 368 331 335
25. Zhao C., Wang I., Lehrer R. I. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett: 1996; 396 319 322 (Pubitemid 26377848)
26. Harder J., Bartels J., Christophers E. et al. A peptide antibiotic from human skin. Nature: 1997; 387 861
27. Harder J., Bartels J., Christophers E. et al. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. JBiol Chem: 2001; 276 5707 5713
28. Kraemer B. F., Campbell R. A., Schwertz H. et al. Novel anti-bacterial activities of β-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation. PLoS Pathog: 2011; 7 e1002355
29. Valore E. V., Park C. H., Quayle A. J. et al. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest: 1998; 101 1633 1642 (Pubitemid 28198492)
30. Voss E., Wehkamp J., Wehkamp K. et al. NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J Biol Chem: 2006; 281 2005 2011 (Pubitemid 43845788)
31. Schlee M., Harder J., Köten B. et al. Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. Clin Exp Immunol: 2008; 151 528 535 (Pubitemid 351160737)
32. Peyrin-Biroulet L., Beisner J., Wang G. et al. Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci USA: 2010; 107 8772 8777
33. Tollin M., Bergman P., Svenberg T. et al. Antimicrobial peptides in the first line defence of human colon mucosa. Peptides: 2003; 24 523 553
34. Nuding S., Zabel L. T., Enders C. et al. Antibacterial activity of human defensins on anaerobic intestinal bacterial species: a major role of HBD-3. Microbes Infect: 2009; 11 384 393
35. Ozturk A., Famili P., Vieira A. R. The antimicrobial peptide DEFB1 is associated with caries. J Dent Res: 2010; 89 631 636
36. Schaefer A. S., Richter G. M., Nothnagel M. et al. A 3 UTR transition within DEFB1 is associated with chronic and aggressive periodontitis. Genes Immun: 2010; 11 45 54
37. Kocsis A. K., Lakatos P. L., Somogyvári F. et al. Association of beta-defensin 1 single nucleotide polymorphisms with Crohns disease. Scand J Gastroenterol: 2008; 43 299 307 (Pubitemid 351238353)
38. Lehrer R. I., Rosenman M., Harwig S. S. et al. Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods: 1991; 137 167 173
39. Wilson M. Microbial Inhabitants of Humans - Their Ecology and Role in Health and Disease. University College London Cambridge University Press: 2005
40. Schroeder B. O., Wu Z., Nuding S. et al. Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1. Nature: 2011; 469 419 423
41. Lehrer R. I. Immunology: Peptide gets in shape for self-defence. Nature: 2011; 469 309 310
42. Nagy E. Anaerobic infections: update on treatment considerations. Drugs: 2010; 70 841 858
43. Holmgren A. Enzymatic reduction-oxidation of protein disulfides by thioredoxin. Meth Enzymol: 1984; 107 295 300
44. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem: 1989; 264 13963 13966 (Pubitemid 19214215)
45. Rubartelli A., Bajetto A., Allavena G. et al. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem: 1992; 267 24161 24164
46. Sido B., Giese T., Autschbach F. et al. Potential role of thioredoxin in immune responses in intestinal lamina propria T lymphocytes. Eur J Immunol: 2005; 35 408 417 (Pubitemid 40331318)
47. Curbo S., Gaudin R., Carlsten M. et al. Regulation of interleukin-4 signaling by extracellular reduction of intramolecular disulfides. Biochem Biophys Res Commun: 2009; 390 1272 1277
48. Magalhaes J. G., Tattoli I., Girardin S. E. The intestinal epithelial barrier: how to distinguish between the microbial flora and pathogens. Semin Immunol: 2007; 19 106 115 (Pubitemid 46810286)
49. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol: 2008; 8 411 420 (Pubitemid 351733416)
50. Wehkamp J., Salzman N. H., Porter E. et al. Reduced Paneth cell alpha-defensins in ileal Crohns disease. Proc Natl Acad Sci USA: 2005; 102 18129 18134 (Pubitemid 41798513)
51. Nuding S., Fellermann K., Wehkamp J. et al. Reduced mucosal antimicrobial activity in Crohns disease of the colon. Gut: 2007; 56 1240 1247 (Pubitemid 47300425)
52. Wehkamp J., Koslowski M., Wang G. et al. Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohns disease. Mucosal Immunol: 2008; 1 01 S67 S74
53. Perminow G., Beisner J., Koslowski M. et al. Defective paneth cell-mediated host defense in pediatric ileal Crohns disease. Am J Gastroenterol: 2010; 105 452 459
54. Tamaki H., Nakamura H., Nishio A. et al. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production. Gastroenterology: 2006; 131 1110 1131
55. Scudiero O., Galdiero S., Cantisani M. et al. Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity. Antimicrob Agents Chemother: 2010; 54 2312 2322